Nom du produit:4-Methylimidazo[1,2-a]quinoxaline
IUPAC Name:4-methylimidazo[1,2-a]quinoxaline
- CAS:68008-53-7
- Formule moléculaire:C11H9N3
- Pureté:97%
- Numéro de catalogue:CM222142
- Poids moléculaire:183.21
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:68008-53-7
- Formule moléculaire:C11H9N3
- Point de fusion:-
- Code SMILES:CC1=NC2=C(N3C1=NC=C3)C=CC=C2
- Densité:
- Numéro de catalogue:CM222142
- Poids moléculaire:183.21
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
- Imidazopyrazines
- In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.